glp-1-based therapies GLP-1 therapy appears to reduce binge eating type behaviours in people with obesity, based upon this recently published systematic review and meta-analysis eClinicalMedicine, 2026, 104007, ISSN 2589-5370 GLP-1 receptor agonists and next-generation
Description
Die berzeugendste Evidenz liegt fr Menschen mit vorbestehender atherosklerotischer Herz-Kreislauf-Erkrankung vor (41)
100 nM, Tocris) was used as a GLP-1R agonist
While the absolute risk remains lowestimated at 0.3% to 0.5% over 20 years of usefurther investigations are needed to confirm whether similar risks exist for Wegovy, Ozempics counterpart for obesity treatment
N Engl J Med 391: 11931205
The first step is a consultation at Optimal Health Medical
M.BaskinD
